Le Lézard
Classified in: Health, Science and technology
Subject: TDS

Explore Anju's AI Roadmap at the 20th Annual Meeting of ISMPP


FORT LAUDERDALE, Fla., April 23, 2024 /PRNewswire/ -- Anju, global pioneer in tailored life science solutions, is proud to announce its participation as an exhibitor at the 20th Annual Meeting of ISMPP, the International Society for Medical Publication Professionals. This year's meeting centers on the art and science of medical publications and communications and the power of its impact to humanize healthcare.

ISMPP brings together medical publications and communications professionals to discuss the latest trends, innovations, and best practices in scientific communications. Anju's presence at this global conference underscores its commitment to improved standards and best practices in the medical publications and communications professions through innovative technology and solutions.

Attendees are invited to stop by Anju's booth #30 to meet with their team of experts and experience live demonstrations of their cutting-edge solutions. From medical information management to publication planning and pharmacovigilance, Anju offers a comprehensive suite of products designed to address the complex needs of the life sciences industry.

"The Anju team is excited to showcase the newest features of Pubstrat MAX and announce our partnership with 9Labs," said Reed McLaughlin, SVP of Sales at Anju. "The integration capabilities with Polarix.io, industry leading platform from 9LABS for the development, distribution and utilization of Scientific Communication Platforms, demonstrates our commitment to providing our customers the most sophisticated solutions."

Meet with Anju throughout the conference to discuss how their solutions can help you optimize your medical affairs processes, improve efficiency, and drive better outcomes for patients. Whether seeking to enhance their medical information management capabilities, ensure compliance with regulatory requirements, or streamline pharmacovigilance operations, Anju has the expertise and technology to support their needs.

Don't miss the opportunity to visit Anju's booth #30 at ISMPP and get an insider look into Pubstrat MAX's innovative AI Roadmap. For more information about Anju and our comprehensive suite of software solutions, please visit https://www.anjusoftware.com/.

About Anju Software:
Anju Software is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company's flagship products, lead the way in reducing complexities in the drug and device discovery and commercialization process. Anju is a portfolio company of Abry Partners serving the worldwide pharmaceutical, biotech and contract research Life Sciences markets.

For media inquiries, please contact:
John F. Kouten
JFK Communications, Inc.
+1 609.241.7352
[email protected]

SOURCE Anju Software


These press releases may also interest you

3 mai 2024
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

3 mai 2024
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

3 mai 2024
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

3 mai 2024
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

3 mai 2024
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

3 mai 2024
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: